to the pattern of other new technologies in medicine, the precise application and use for 3D imaging remain undefined thus far.
Breast augmentation provides an ideal application for evaluating 3D imaging and simulation. As the most commonly performed aesthetic procedure in the United States, breast augmentation requires a highly individualized approach to addressing changes in volume and shape. The 3D modeling system gives surgeons the ability to measure volumes unobtainable through conventional two-dimensional (2D) photographs or physical examination. This tool provides an objective method to identify and document preexisting breast asymmetry with system software that can recognize differences in shape and volume. Furthermore, the program creates simulated representative photographs of patients prior to surgery. These features may assist in preoperative planning and yield better communication with patients about expected results.
Documentation of the accuracy and reproducibility of 3D technology has begun to appear in the literature for various aspects of breast surgery. These have included breast augmentation, reduction mammaplasty, and mastopexy. 3 The available evidence indicates potential value for this technology, but a need for further studies using 3D measurements to validate the camera's reliable use still remains. [4] [5] [6] The purpose of this study was to measure the accuracy of the Portrait 3D system by comparing simulated to actual breast volumes, and to determine reproducibility of the volumetric analysis by comparing different observer assessments.
MethOds

Patient Cohort
All consecutive patients who underwent breast augmentation and imaging with the Portrait 3D system between May and August 2009 were identified and their charts reviewed. Thirty patients with both preoperative and postoperative 3D imaging were identified. Portrait 3D imaging was performed at the initial consultation and at least 6 weeks postoperatively. Patients received silicone or saline implants based on patient preference. The manufacturer's imaging software relied on accurate images of the entire breast surface to create volume estimations. It should be noted that, with this software, ptotic breasts can cause an overestimation of volume because the undersurface is concealed; therefore, 4 patients with clinically significant ptosis, as deemed by agreement among the study authors, were excluded for the purposes of this study. Four patients underwent concomitant breast procedures (eg, mastopexy, breast reduction) along with augmentation and were also excluded from the study. The remaining 22 patients comprised the study population, and their charts were reviewed for type of implant, length of follow-up, implant location, type of incision, and the emergence of complications or revisions. This study was approved by the Louisiana State University Institutional Review Board.
Imaging Technique and Volume Assessment
Preoperative imaging using the Portrait 3D system was performed during initial consultation. Patients undergoing breast augmentation were routinely scheduled for follow-up at 1 week and 6 weeks postoperatively. Imaging with the Portrait 3D system was repeated at the 6-week postoperative visit. Volumetric analysis was performed by 2 independent surgeons (a plastic surgery resident [AF, observer 1] and an attending surgeon [KK, observer 2]) using the Portrait 3D software. The required landmarks were placed on the lateral border of the breast, sternal notch, nipple, upper areolar border, inframammary fold, and medial breast. The Portrait 3D software extrapolated breast volumes from the data points ( Figure 1 ). Fine adjustments to the points were made by the surgeon to ensure the actual total breast was included and to improve accuracy. The estimated implant volume was derived by calculating the difference between the preoperative and postoperative breast volume, as measured by the 3D software. Actual implant volumes were collected from patient charts and entered into a spreadsheet by a separate independent surgeon; this was done to avoid bias in the simulation measurements. Both observers inspected each preoperative and postoperative 3D image and separately recorded a volume measurement onto the spreadsheet.
Statistical Analysis
The primary objective was to determine the accuracy and reproducibility of 3D volumetric measurements using the Portrait 3D system. Actual implant volume was the implant size, as reported by the manufacturer. Simulated implant volume was estimated by subtracting the preoperative volume measurement from the postoperative one. An absolute volume difference and a percent difference (implant volume difference divided by actual implant volume) were calculated and reported. All volumes are reported in cubic centimeters (cc) with standard deviations; standard error of the mean was given for volumes compared by their mean. Student t test with normally distributed continuous variables was used for comparison of observer differences, as well as differences between simulated and actual implant volumes. To assess limits of agreement between observers, the intraclass correlation coefficient (ICC) was calculated. The Altman scale was used in the classification of the reliability values. 7 ICC values under 0.20 were considered poor; 0.21 to 0.40, fair; 0.41 to 0.60, moderate; 0.61 to 0.80, good; and 0.81 to 1.00, excellent. This measure of reliability was evaluated by means of using 2 observers (ie, test-retest analysis) and reported with ICC values. Internal consistency was assessed using Cronbach α and reported with a 95% confidence interval. Statistical analysis was performed using SPSS (version 19; SPSS, Inc, an IBM Company, Chicago, Illinois). P values were 2-sided, and values <.05 were considered statistically significant. Absolute differences between the simulated and actual implant volumes were calculated: |implant volume -simulated implant volume| = implant volume difference.
The percentage was calculated by dividing the implant volume difference by the actual implant volume.
Implant volume difference Implant volume = % difference
To compare simulated with actual implant volume, the 2 observers' estimated volumes were averaged and reported as a mean.
Results
Characteristics of Patient Cohort
Thirty patients underwent breast augmentation between May and August 2009. Of these, 22 patients (44 breasts) had postoperative imaging performed using the Portrait 3D system and were included for study. Their characteristics are presented in Table 1 , and results are shown in Figures 2 through 5. All patients were female, and all had submuscular implants placed via an inframammary incision. The decision for silicone (50%, n = 11) versus saline (50%, n = 11) implants was decided on an individual basis. Implant size was also decided by patient preference, in conjunction with the surgeon, and was an average of 338 cc (range, 250-400). The median time to follow-up was 7.7 weeks (mean, 13.7 weeks; range, 5.4-75.9 weeks). On average, the right preoperative breast was slightly smaller than the left (271 vs 284 cc); therefore, implant sizes varied slightly between the 2 sides (range, 250-400 cc and 270-400 cc on the right and left, respectively). Postoperatively, the right breast remained similarly smaller (602 vs 610 cc on the right and left, respectively). The simulated implant volumes corresponded to the actual ones at 322 versus 323 cc, for the 
Comparison of Breast Volumes Between Independent Observers
Each observer estimated breast volumes of every patient using the 3D images and associated software. No statistical difference was seen between the 2 observers' estimations of preoperative volume (271 vs 268 cc, P = .49 for the right breast; 284 vs 284 cc, P = 1.0, for the left breast). For the postoperative volume measurement, no statistical difference was seen between the 2 observers for either the right or left breast (602 vs 591 cc, P = .14 for the right breast; 611 vs 604 cc, P = .37 for the left breast; Table 2 ). The internal consistency, limits of agreement, and test-retest reliability between observers are also presented in Table 2 . The results showed excellent intraobserver reliability (ICC >0. 
Comparison of Actual Implant Size to Simulated Volume by the Portrait 3D System
A comparison between actual and simulated implant volumes of the 22 patients is presented in Table 3 . Volumes differed between the 3D simulation and the actual implant size by 0.4% to 30% with an average difference of 12% (10.9% and 13.5% for the right and left breasts, respectively). When analyzing data from the Portrait 3D system, the average simulated implant size was 322 cc (range, 202-495 cc), whereas the actual mean size was 339 cc (range, 250-400 cc). On comparison between actual and simulated volumes, no difference was observed (338 vs 322 cc, P = .56 for the right breast; 339 vs 322 cc, P = .33 for the left breast). The absolute volume differences for the right and left breasts are also presented in Table 3 . A similarity in absolute volume difference for breasts of the same patient was noted (eg, patient 1, right: 9% and left: 5% vs patient 4, right: 21% and left: 20%).
disCussiOn
The addition of 3D imaging to the cache of the plastic surgeon has numerous potential aesthetic and reconstructive applications. In particular, breast surgery is ideally suited for 3D technology. As a visual tool, it facilitates communi- cation with patients and demonstrates expected outcomes by using the patient's own body as a model. This is in contrast to previous methods of relying on other patients' before and after photographs, using magazine pictures, or simulating volume changes by placing "trial" implants into the patient's bra. The use of 3D imaging and computerized measurements brings a new dimension into surgical planning. Volume measurements made by the camera can objectively identify preexisting breast asymmetry, which may alter plans for augmentation or reconstruction. In the realm of reconstruction, it may be possible to measure volumes of the contralateral intact breast when planning autologous reconstruction for the other side. By knowing this measurement, flap volumes can be contoured to a closer match, ensuring better symmetry and possibly decreasing the need for subsequent revisions. 3D imaging may also prove to be a valuable tool in evaluating percent retention after autologous fat grafting.
However, before investing in this technology and allowing patients to rely on its results, it is important to validate the data the software provides. Losken et al 4 evaluated the 3dMD system, comparing its calculated volumes to those of mastectomy specimens determined by water displacement. They found a difference between the 2 volumes at −2%. In our present study, we evaluated the Portrait 3D system's simulated volumes against known implant volumes. We determined a variation of volume by up to 30% (mean, 12.2%). This discrepancy between simulated and actual volumes appeared to be consistent in individual patients (eg, right vs left breast). To exemplify, in patient 1 (Table 3) , we noted a difference of 9% and 5% between simulated and actual volumes in the right and left breasts, respectively. Similarly, in patients with a greater degree of variation (patient 4, Table 3 ), a similar discrepancy was observed between breasts (21% and 20% in the right and left breasts). These observations may be the result of the patient's body habitus or breast shape and needs further investigation. For our purposes, this degree of error has been acceptable and is still more accurate than other methods (eg, magazine photos or placing trial implants into a patient's bra). Despite this, the lack of precision should be appropriately discussed with patients, and it is hoped that future software generations will improve upon this difference. Essentially, simulated volume from 3D technology is currently the most accurate method available. We also evaluated the reproducibility of the volume measurements by using 2 observers to create volume A stated limitation to the ease of 3D imaging includes the manual positioning of anatomical markers; in this way, the system can be more time-consuming in terms of calculating measurements and therefore less practical in a busy clinical setting. However, our current study demonstrates the excellent reproducibility of identifying these landmarks using 2 surgeons, thus demonstrating low operator dependence. In future studies, this reliability should also be confirmed for nonsurgeons to determine if other members of the office staff can consistently obtain similar volume measurements. A "4-Dimensional" breast imaging system using Precision Light Imaging (PLI) software (Precision Light, Inc, Los Gatos, California) obviates the need for manual marker placement by using an automated process. 8, 9 This software technology appears promising, 8, 9 but with the high reproducibility demonstrated in the current study, it is likely that other office staff members will quickly and reliably be able to perform the measurements at the time of image capture with 3D software until PLIlike software becomes more affordable and compatible with various camera systems. The PLI software may also better account for breast ptosis, which would be a significant advantage over current software systems. 8, 9 An additional limitation to our study includes a relatively short period for obtaining postoperative images (mean, 13.7 weeks). Unfortunately, since this study was conducted as a retrospective chart review, we were unable to obtain longerterm postoperative images for our entire study population. Longer-term information may confirm our findings, but our current follow-up time of over 3 months is sufficient time for edema to resolve and is therefore acceptable for our purposes. In fact, with a longer follow-up, breast tissue may be concealed as the implant drops into its final position, making longer-term images less accurate. Currently, the primary uses of the system are to (1) assist in operative planning by identifying differences in preoperative breast symmetry and volume and (2) guide the patient in selecting the size and projection of the final implant. Our study used the manufacturer's implant size to confirm our imaging findings. This process, although within a clinically acceptable margin of error, may not account for displacement or compression of the implant in the patient. Future studies to further validate our findings should include magnetic resonance imaging volume measurements.
